Biotech analysts see plunge as buying opportunity
August 12, 2011 at 14:35 PM EDT
While most investors fled for safer havens this week, biotech analysts were advising clients to take advantage of discounted stock prices.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.